This week, the Centers for Medicare and Medicaid Services (CMS) announced it will provide access to some GLP-1 medications for $50 per month to eligible Medicare beneficiaries. The medications will be available through a new Medicare Bridge Program, a temporary demonstration program which will begin on July 1, 2026. Medicare beneficiaries must meet certain clinical criteria to qualify for coverage of the medications. More information about the bridge program including the clinical criteria and which GLP-1 medications will be available through the program can be found here on CMS’s website.
The Endocrine Society is a leading voice urging Congress and the Administration to expand access to anti-obesity medications (AOM). We strongly support the creation of this program and have also supported previous proposals to expand access to AOMs. We also support the Treat and Reduce Obesity Act (TROA) that would allow Medicare to cover AOMs for weight loss and expand Medicare coverage of Intensive Behavioral Therapy (IBT), which is an effective lifestyle intervention for treating obesity. We will continue to keep members apprised of developments.
The Endocrine Society represents the interests of members to policymakers and we have several ways for you to join us in advocacy. Currently, we have two online advocacy campaigns on high priority issues: increasing funding for the National Institutes of Health and making insulin more affordable.
Join us to show our strength as a community that cares about endocrinology. These campaigns take only a minute of your time, but they are influential and make a difference. Please take action today!
The Endocrine Society provides comments and makes recommendations on many policy issues. Below are the most recent policy communications from April that we sent to the US Congress and Federal Agencies:
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.
